1. Monash Health
  2. Monash Health research
  3. Clinical Trials
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/56896
Full metadata record
DC FieldValueLanguage
dc.coverage.spatialMonash Children's Hospital-
dc.date.accessioned2025-12-24T00:55:15Z-
dc.date.available2025-12-24T00:55:15Z-
dc.date.issued2022-01-17-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/56896-
dc.description.abstractThis study is aimed at establishing tolerable and potentially effective doses of two medicinal cannabis products in paediatric palliative care. Who is it for? Participants may be eligible for this study if they are aged 6 months to 21 years, have advanced cancer (metastatic or locally advanced solid tumours, brain tumours or advanced hematological malignancies) and have been referred to or are known by the paediatric palliative service. Study details Participants will undergo baseline measurements, before being randomly allocated to either of two cannabis oil treatments which will be delivered daily for a total of 6 weeks. Participants will visit the clinic weekly to have their symptom burden assessed. Results from this study will help determine clinical dosing of medicinal cannabis for relief of symptom burden in children with advanced cancer.-
dc.titleMedicinal Cannabis for symptom burden in children with advanced cancer-
dc.typeClinical trial-
dc.identifier.urlhttps://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382024-
dc.identifier.externalACTRN12622000037707-
item.openairetypeClinical trial-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Clinical Trials
Show simple item record

Page view(s)

38
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.